About the Advanced Regenerative Manufacturing Institute
Our mission is to advance the bioeconomy of the United States. The Institute’s work will positively impact not only manufacturing but also healthcare and education and workforce development for the nation.
Manufacturing scalability, process and partnership.
There are 400,000 people worldwide right now on waiting lists for organs. What if we could create lungs, livers or corneas at scale? It would be unprecedented.
Our goal is to move highly specialized regenerative medicine – engineering or regenerating human cells, tissues and organs – from lab to production to cure diseases and improve quality of life.
ARMI’s Leadership Team
DEAN KAMEN
Executive Director & Chairman of the Board, ARMI
Maureen Toohey
Deputy Executive Director & Secretary of the Board
Thomas Bollenbach, Ph.D.
Chief Technology Officer
Jim Scott
Chief Administrative Officer
Jennifer MacDonald, M.D.
Chief Operating Officer
News Highlights
Events
Events
-
-
Cell & Gene Therapy International 2026
Hynes Convention Center 900 Boylston Street, Boston, MA, United StatesJoin ARMI at Cell & Gene Therapy International during Biotech Week Boston, where Chief Regulatory Officer Dr. Richard McFarland will moderate a panel on decentralized manufacturing for cell therapies.
-
-
Cell & Gene Meeting on the Mesa 2026
Arizona Biltmore 2400 E Missouri Ave, Phoenix, AZ, United StatesARMI will attend the Cell & Gene Meeting on the Mesa 2026, one of the industry’s leading conferences focused on overcoming the commercialization, manufacturing, and investment challenges facing advanced therapies
-
ARMI Investment Summit 2026
150 Dow Street 150 Dow Street, Manchester, NH, United StatesOver the course of a single day, the ARMI Investment Summit will connect founders, investors, commercialization experts, manufacturers, and industry leaders to accelerate innovation through expert panel discussions, the BioFab Startup Lab Pitch Competition, and meaningful networking opportunities.
-
-
TERMIS-AM 2026
New Orleans, LouisianaARMI will attend TERMIS-AM 2026, the premier North American conference for tissue engineering and regenerative medicine, bringing together researchers, clinicians, industry leaders, and innovators advancing the future of regenerative therapies.
